Key Drivers
- High operating margins
- Negative free cash flow
- Low asset turnover
AIAI Summary
Agree Realty has transitioned from a steady dividend net-lease REIT into a growth-through-deployment platform, so the investment now hinges on disciplined execution of acquisitions/development (target ~7% cap rates) and near-term financing access rather than being a safe yield play. Key actionable monitorables: quarterly FCF conversion, acquisition cap rates vs. initial underwriting, forward-equity dilution cadence, and leverage metrics (net debt/EBITDA) — any funding dislocation or cap‑rate re‑pricing would materially impair NAV and the dividend.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High operating margins
- •Negative free cash flow
- •Low asset turnover
High margins and positive operating cash flow are outweighed by very low asset turnover, heavy capex driving negative free cash flow and thin liquidity, making the dividend and current rich valuation risky. #strong-margins
Price Behavior
Key Price Behavior Insights:
- •Below 21-day
- •Resistance ~82
- •Support 77–79
ADC has pulled back over the last month from a March high near $81.92 to close $76.15, trading below the last month's 21-day average (~$79.8) and testing near-term support around $77–$79 with resistance at ~$82.
~6.8% decline from $81.92 to $76.15 over the last month, breaking below the last month's 21-day average
Sentiment & News
Key News Insights:
- •Dividend lift
- •Institutional flows
- •Near‑term readouts
Agree Realty is drawing dividend-focused investor flows and analyst support while antibody‑drug conjugate developers push near‑term clinical readouts and financing moves into mid‑2026.
Expect Agree Realty to trade as a defensive, income-focused name while ADC biotech stocks stay catalyst-driven and potentially volatile ahead of mid‑2026 data
Similar Companies in Real Estate
Other companies in the same sector with AI ratings